Callan Family Office’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.22M Sell
14,273
-399
-3% -$119K 0.1% 218
2025
Q4
$4.01M Buy
14,672
+1,551
+12% +$421K 0.09% 219
2025
Q3
$3.55M Sell
13,121
-518
-4% -$141K 0.11% 189
2025
Q2
$3.76M Buy
13,639
+11,075
+432% +$3.01M 0.12% 187
2025
Q1
$680K Sell
2,564
-7,320
-74% -$1.81M 0.05% 270
2024
Q4
$2.3M Buy
+9,884
New +$2.27M 0.15% 132

Other funds holding CME

Callan Family Office's CME Position: Q1 2026 in Review

Callan Family Office reduced its CME Group (CME) stake by 2.7% in Q1 2026, selling an estimated $119K and leaving 14,273 shares worth $4.22M. The position accounts for 0.1% of the portfolio, ranked #218.

Callan Family Office first reported a position in CME in Q4 2024 and has held it in 6 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Callan Family Office held 14,273 shares of CME Group worth $4.22M as of Q1 2026.
  • Callan Family Office sold 399 CME Group shares in Q1 2026, an estimated $119K.
  • CME Group made up 0.1% of Callan Family Office's portfolio in Q1 2026, its #218 holding.
  • Callan Family Office first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.